Draupnir Bio
Drug Discovery · Neurology & CNS Therapeutics
Lately:1 news story in 90 daysFollow changes →
Facts
as of Nov 19, 2026Draupnir Bio is developing new innovative therapies for patients.
- Website
- draupnir.bio
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Financials
Funding rounds, investors and revenue on record.
$13MTotal raised
SeedLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
2024
$13M
Sources: funding announcements, grant and company registers
Money
Draupnir Bio has $13M paid in by investors, lenders and donors.
$13MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
$13MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Milestones
Jul 17, 2024
Raised a round Seed $13M · YahooFinance
Jun 23, 2021
Each milestone is dated by its source: registers, filings, the press
